Semaglutide is a synthetic, modified GLP-1 analogue used in qualified laboratory research involving GLP-1 receptor signalling, acylated peptide stability and incretin pathway models. It contains sequence modifications and a fatty-acid side chain designed for altered peptide behaviour.
Semaglutide is a synthetic, modified GLP-1 analogue used in qualified laboratory research involving GLP-1 receptor signalling, acylated peptide stability and incretin pathway models. It contains sequence modifications and a fatty-acid side chain designed for altered peptide behaviour. This material should be supplied strictly as a research compound and not as a medical product.
